BNP Paribas Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Sell |
54,742
-309
| -0.6% | -$12.6K | ﹤0.01% | 1080 |
|
|
2025
Q4 | $2.23M | Buy |
55,051
+54,724
| +16,735% | +$2.38M | ﹤0.01% | 1049 |
|
|
2025
Q3 | $15K | Hold |
327
| – | – | ﹤0.01% | 1488 |
|
|
2025
Q2 | $17K | Buy |
+327
| New | +$17.9K | ﹤0.01% | 1565 |
|
|
2024
Q3 | – | Sell |
-320,543
| Closed | -$22.2M | – | 907 |
|
|
2024
Q2 | $22.2M | Buy |
320,543
+2,549
| +0.8% | +$186K | 0.06% | 275 |
|
|
2024
Q1 | $25.5M | Buy |
317,994
+58,959
| +23% | +$5.26M | 0.07% | 271 |
|
|
2023
Q4 | $28.4M | Buy |
259,035
+9,664
| +4% | +$999K | 0.08% | 255 |
|
|
2023
Q3 | $25.1M | Buy |
249,371
+23,540
| +10% | +$2.7M | 0.08% | 259 |
|
|
2023
Q2 | $30.7M | Sell |
225,831
-101,217
| -31% | -$12.4M | 0.1% | 223 |
|
|
2023
Q1 | $34M | Sell |
327,048
-922
| -0.3% | -$89.2K | 0.12% | 191 |
|
|
2022
Q4 | $29.1M | Buy |
327,970
+7,939
| +2% | +$659K | 0.1% | 227 |
|
|
2022
Q3 | $25.7M | Buy |
320,031
+23,448
| +8% | +$2.21M | 0.1% | 231 |
|
|
2022
Q2 | $28.4M | Buy |
296,583
+51,306
| +21% | +$6.16M | 0.11% | 218 |
|
|
2022
Q1 | $36.4M | Sell |
245,277
-36,160
| -13% | -$5.05M | 0.13% | 198 |
|
|
2021
Q4 | $39.9M | Buy |
281,437
+5,465
| +2% | +$774K | 0.13% | 191 |
|
|
2021
Q3 | $36.1M | Buy |
275,972
+3,334
| +1% | +$436K | 0.13% | 191 |
|
|
2021
Q2 | $37.5M | Buy |
272,638
+4,959
| +2% | +$679K | 0.13% | 192 |
|
|
2021
Q1 | $35M | Sell |
267,679
-63,689
| -19% | -$7.66M | 0.14% | 170 |
|
|
2020
Q4 | $37.1M | Buy |
331,368
+67,484
| +26% | +$6.39M | 0.17% | 150 |
|
|
2020
Q3 | $20.8M | Buy |
263,884
+132,587
| +101% | +$10.8M | 0.12% | 214 |
|
|
2020
Q2 | $9.45M | Buy |
+131,297
| New | +$9.13M | 0.06% | 314 |
|
|
2016
Q3 | – | Sell |
-163,454
| Closed | -$7.8M | – | 1087 |
|
|
2016
Q2 | $7.8M | Buy |
163,454
+20,751
| +15% | +$879K | 0.07% | 376 |
|
|
2016
Q1 | $5.99M | Sell |
142,703
-49,366
| -26% | -$1.94M | 0.05% | 421 |
|
|
2015
Q4 | $8.46M | Buy |
192,069
+19,583
| +11% | +$850K | 0.07% | 336 |
|
|
2015
Q3 | $8.23M | Sell |
172,486
-65,109
| -27% | -$3.57M | 0.07% | 339 |
|
|
2015
Q2 | $13.8M | Sell |
237,595
-12,981
| -5% | -$700K | 0.11% | 261 |
|
|
2015
Q1 | $12.7M | Sell |
250,576
-17,359
| -6% | -$851K | 0.1% | 290 |
|
|
2014
Q4 | $12M | Buy |
267,935
+22,356
| +9% | +$937K | 0.1% | 270 |
|
|
2014
Q3 | $9.05M | Buy |
245,579
+25,669
| +12% | +$1.02M | 0.07% | 305 |
|
|
2014
Q2 | $9.71M | Sell |
219,910
-83,491
| -28% | -$3.79M | 0.08% | 294 |
|
|
2014
Q1 | $13.2M | Buy |
303,401
+213,468
| +237% | +$9.51M | 0.1% | 239 |
|
|
2013
Q4 | $3.82M | Buy |
+89,933
| New | +$3.42M | 0.03% | 463 |
|
Other funds holding CNMD
VPM
VCM
CB
BNP Paribas Asset Management's CNMD Position: Q1 2026 in Review
BNP Paribas Asset Management reduced its CONMED (CNMD) stake by 0.56% in Q1 2026, selling an estimated $12.6K and leaving 54,742 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1080.
BNP Paribas Asset Management first reported a position in CNMD in Q4 2013 and has held it in 32 quarters since. The position peaked at $39.9M in Q4 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- BNP Paribas Asset Management held 54,742 shares of CONMED worth $1.94M as of Q1 2026.
- BNP Paribas Asset Management sold 309 CONMED shares in Q1 2026, an estimated $12.6K.
- CONMED made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1080 holding.
- BNP Paribas Asset Management first reported a position in CONMED in Q4 2013 and has held it in 32 quarters since.
- BNP Paribas Asset Management's CONMED position peaked at $39.9M in Q4 2021.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.